Novo Nordisk A/SNVONYSE
Loading
Interest Income Over TimeExpanding
Percentile Rank100
3Y CAGR+238.7%
5Y CAGR+97.1%
Studio
Year-over-Year Change

Income earned from interest-bearing assets

3Y CAGR
+238.7%/yr
vs +47.1%/yr prior
5Y CAGR
+97.1%/yr
Recent acceleration
Acceleration
+191.6pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
29.7x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$9.29B+405.4%
2024$1.84B+71.9%
2023$1.07B+347.3%
2022$239.00M+3.5%
2021$231.00M-26.1%
2020$312.56M+387.2%
2019$64.15M+25.8%
2018$51.00M-26.1%
2017$69.00M+32.7%
2016$52.00M-